21.03.2025
Marion Walsmann visits GRINTECH
Member of the European Parliament exchanges views with GRINTECH team on reducing bureaucracy and the importance of EU funding
On March 21, GRINTECH welcomed Marion Walsmann (CDU), Member of the European Parliament, to our high-tech company in Jena. Walsmann has been a Member of the European Parliament since 2019 and is a member of the Committee on the Internal Market and Consumer Protection. During her visit, she wanted to gain an insight into the current challenges facing innovative, globally active SMEs like ours.
We presented our premises in Otto-Eppenstein-Straße during an informal tour of the company and provided a glimpse behind the scenes of our production and administration. In an open and informative exchange, the main topic of discussion was how bureaucracy can be reduced for the economy. A topic that is also being discussed intensively at European level in Brussels. Like many companies, we at GRINTECH also see great potential in reducing bureaucratic hurdles. With fewer legal requirements, innovations can be driven forward more efficiently and implemented more quickly. Reducing unnecessary bureaucracy is therefore a top priority for us.
Our colleagues also gave Ms. Walsmann an overview of the EU-funded research projects in which we are involved. This funding enables us to make important progress in medical technology and photonics while at the same time concentrating on our core competencies. We hope that these funding priorities will continue to be supported so that we – and many other partners – can drive forward pioneering innovations in these highly specialized areas of technology.
Following her visit, Ms. Walsmann thanked us for the exciting insight into our work and emphasized that the joint dialogue had provided her with many valuable ideas for her political work in Brussels and Strasbourg.
We are delighted with this positive feedback and the open and appreciative exchange with politicians. As GRINTECH, we will continue to contribute to the innovative further development of medical technology and photonics and are happy to engage in joint discussions.
